An easy-to-use nomogram to predict overall survival (OS) at 6 months after initiation of FOLFIRINOX first-line chemotherapy in patients (pts) with metastatic pancreatic cancer (mPC).

Affiliation auteurs!!!! Error affiliation !!!!
TitreAn easy-to-use nomogram to predict overall survival (OS) at 6 months after initiation of FOLFIRINOX first-line chemotherapy in patients (pts) with metastatic pancreatic cancer (mPC).
Type de publicationJournal Article
Year of Publication2018
AuteursFornaro L, Leone F, Vienot A, Gardini ACasadei, Vivaldi C, Lombardi P, Meurisse A, Passardi A, Vasile E, De Luca E, Edeline J, Musettini G, Satolli MAntonietta, Neuzillet C, Spadi R, Vernerey D, Falcone A, Clerico M, Lievre A, Montagnani F
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.4_suppl.394